Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
Clinical trial NCT04820179 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04820179
- Sponsor
- University of Arizona
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2026-02-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.